In agreement with the mouse model, a small study showed that 15 individuals with loss-of function ABCA1 mutations showed decreased insulin secretion, mild hyperglycemia but no difference in insulin response to an oral glucose challenge measured by hyperglycemic clamp [60]. This evidence concerns the gene INS and Hyperglycemia.